Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Demetroulis, C.
Right arrow Articles by Naftalin, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demetroulis, C.
Right arrow Articles by Naftalin, A. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 2, 365-369, February 2001
© 2001 European Society of Human Reproduction and Embryology

A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure

Constantinos Demetroulis, Ertan Saridogan,1, Dattakumar Kunde and Alan A. Naftalin,2

Department of Obstetrics and Gynaecology, Newham General Hospital, London, UK

A prospective randomized control trial was designed to assess the effectiveness of single dose, 800 µg misoprostol administered p.v. compared with surgical evacuation for the treatment of early pregnancy failure. A total of 80 women with a diagnosis of early pregnancy failure were randomized to study (vaginal misoprostol) and control (surgical curettage) groups. Success of treatment, side-effects as assessed during, immediately after and 10 days after treatment, and patient satisfaction were compared. Intravaginal misoprostol was successful in 82.5% (33 out of 40) of the patients. None of the control group patients required a repeat evacuation. The number of patients who experienced significant abdominal pain following treatment did not differ between the groups. The duration of pain was shorter in the control group; however, they required more analgesics during this short period. The number of patients with significant vaginal bleeding, the duration or severity of bleeding did not show any significant difference between the groups. All 33 patients in the study group who had successful treatment expressed satisfaction, whereas only 58% of the control group did so. In conclusion this randomized control study demonstrated the efficacy and safety of the administration of 800 µg of misoprostol p.v. for the management of early pregnancy failure.

Key words: medical treatment/miscarriage/misoprostol/surgical curettage

1 Present address: Department of Obstetrics and Gynaecology, University College London Hospitals, London, UK

2 To whom correspondence should be addressed at: Newham General Hospital, Glen Road, Plaistow, London E13 8SL, UK.E-mail: anaftalin{at}zetnet.co.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DTBHome page
Which approach for first trimester miscarriage?
DTB, July 1, 2009; 47(7): 77 - 80.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J Trinder, P Brocklehurst, R Porter, M Read, S Vyas, and L Smith
Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial)
BMJ, May 27, 2006; 332(7552): 1235 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
O. S. Tang, C. Y.T. Ong, K. Y. Tse, E. H.Y. Ng, S. W.H. Lee, and P. C. Ho
A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage
Hum. Reprod., January 1, 2006; 21(1): 189 - 192.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. H.S. You and T. K.H. Chung
Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis
Hum. Reprod., October 1, 2005; 20(10): 2873 - 2878.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. Winikoff
Pregnancy Failure and Misoprostol -- Time for a Change
N. Engl. J. Med., August 25, 2005; 353(8): 834 - 836.
[Full Text] [PDF]


Home page
Hum ReprodHome page
G.C.M. Graziosi, H.W. Bruinse, P.J.H. Reuwer, P.H. van Kessel, P.E. Westerweel, and B.W. Mol
Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial
Hum. Reprod., August 1, 2005; 20(8): 2340 - 2347.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.C.M. Graziosi, J.W. van der Steeg, P.H.W. Reuwer, A.P. Drogtrop, H.W. Bruinse, and B.W.J. Mol
Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management
Hum. Reprod., April 1, 2005; 20(4): 1067 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G.C.M. Graziosi, B.W.J. Mol, P.J.H. Reuwer, A. Drogtrop, and H.W. Bruinse
Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial
Hum. Reprod., August 1, 2004; 19(8): 1894 - 1899.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J.S. Bagratee, V. Khullar, L. Regan, J. Moodley, and H. Kagoro
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage
Hum. Reprod., February 1, 2004; 19(2): 266 - 271.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Wieringa-de Waard, J. Vos, G. J. Bonsel, P. J.E. Bindels, and W. M. Ankum
Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation
Hum. Reprod., September 1, 2002; 17(9): 2445 - 2450.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P.T. Wagaarachchi, P.W. Ashok, N. Narvekar, N.C. Smith, and A. Templeton
Medical management of early fetal demise using a combination of mifepristone and misoprostol
Hum. Reprod., September 1, 2001; 16(9): 1849 - 1853.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.